Navigation Links
Mylan Launches Generic Version of Depakote® Sprinkle Capsules
Date:5/23/2011

PITTSBURGH, May 23, 2011 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Divalproex Sodium Capsules USP, 125 mg, the generic version of Abbott's Depakote® Sprinkle Capsules, a treatment for certain types of seizures.  

Divalproex Sodium Capsules had U.S. sales of approximately $89 million for the 12 months ending March 31, 2011, according to IMS Health.

Currently, Mylan has 167 ANDAs pending FDA approval representing $100.3 billion in annual sales, according to IMS Health. Forty-five of these pending ANDAs are potential first-to-file opportunities, representing $25.8 billion in annual brand sales, for the 12 months ending Dec. 31, 2010, according to IMS Health.

Mylan Inc. ranks among the leading generic and specialty pharmaceutical companies in the world and provides products to customers in more than 150 countries and territories. The company maintains one of the industry's broadest and highest quality product portfolios supported by a robust product pipeline; operates one of the world's largest active pharmaceutical ingredient manufacturers; and runs a specialty business focused on respiratory, allergy and psychiatric therapies. For more information about Mylan, please visit www.mylan.com. For more information about generic drugs, please visit www.ChoosingGenerics.com.


'/>"/>
SOURCE Mylan Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Mylan Launches First Generic Version of Xibrom® Ophthalmic Solution
2. Mylan Launches First Generic Version of Amrix® Capsules
3. Mylan Launches Generic Version of Risperdal® M-Tab®
4. Mylan Launches First Generic Version of Femara® Tablets
5. Mylan Launches Generic Version of Famvir® Tablets
6. Mylan Receives Approval for Generic Version of Xalatan® Ophthalmic Solution
7. Mylan Announces Exclusive Distribution Partnership with Humeca to Expand Burn and Wound Care Portfolio
8. Moodys Upgrades Mylan
9. Mylan Confirms First-to-File Patent Challenge Relating to Vivelle-Dot®
10. Mylan Receives Approval for Generic Version of Neurontin® Capsules
11. Mylan Launches First Generic Version of Vfend® Tablets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... N.J. and DETROIT , April ... five children live in poverty, the infant mortality rate is ... at 15 per 1,000 live births. Nearly 6 of 10 ... not receive adequate prenatal care.  These are sobering statistics that ... serving the people of Metro Detroit, is poised to change ...
(Date:4/17/2015)... 2015  Over the next five years, the marijuana industry ... ArcView predicting that 14 more states will legalize recreational marijuana ... market for legal cannabis grew 74 percent in 2014 to ... the market could grow more than fourfold to $11 billion ... stance on marijuana. Cannabiz Mobile Inc. (OTCBB: LGBI) ...
(Date:4/17/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/7qs3dw/corporate ... Reputation of Pharma in 2014 - a Perspective of ... their offering. This independent study, funded by ... with an interest in diabetes on the corporate reputation ... industry as a whole) in 2014. The results from ...
Breaking Medicine Technology:Covenant Community Care to Receive Donated SONIMAGE P3 Handheld Ultrasound from Konica Minolta Medical Imaging 2Covenant Community Care to Receive Donated SONIMAGE P3 Handheld Ultrasound from Konica Minolta Medical Imaging 3Covenant Community Care to Receive Donated SONIMAGE P3 Handheld Ultrasound from Konica Minolta Medical Imaging 4Cannabiz Mobile Analyst Brief: Next Big Thing by Torus IR Issued by BrokerBank Securities, Inc. 2Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 2Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 3Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 4Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 5
... Corporation (Nasdaq: DRRX ) announced today that ... the BIO CEO & Investor Conference on Monday, February ... being held at the Waldorf-Astoria Hotel in New York ... A live audio webcast of the presentation ...
... BD (Becton, Dickinson and Company) (NYSE: BDX ... that it signed a definitive agreement to acquire Accuri ... and manufactures personal flow cytometers for researchers.  The acquisition ... close during the third quarter of fiscal year 2011. ...
Cached Medicine Technology:DURECT to Present at the BIO CEO & Investor Conference 2BD Announces Agreement to Acquire Accuri Cytometers, Inc. 2BD Announces Agreement to Acquire Accuri Cytometers, Inc. 3
(Date:4/18/2015)... PHOENIX, ARIZONA – In March, Mark Ona, ... secure destruction professionals across the United States, earned the ... now display “CSDS” as a professional title with his ... Association of Information Destruction 2015 Annual Conference began - ... the 20 people who took the exam, Ona was ...
(Date:4/17/2015)... Heritage Woods of McLeansboro, a Gardant ... Week Celebration on April 20 with a day full ... body and soul. , The community, which is located ... adults of all incomes, including those on Medicaid, who ... Living Week is observed every April and highlights the ...
(Date:4/17/2015)... New York, NY (PRWEB) April 18, 2015 ... services at their facility, rounding out their list of ... comprehensive care center for patients on the Upper East ... up and running at full capacity. The addition of ... Accelerator, gives their physicians the ability to work with ...
(Date:4/17/2015)... California (PRWEB) April 17, 2015 ... Dr. Kevin Sadati of the Gallery of ... Orange County’s top beauty experts. The publication focused ... lift, facial stem cell fat grafting, eyelid surgery, laser ... facial plastic surgery has resulted in thousands ...
(Date:4/17/2015)... Florida Hospital Wesley Chapel, Florida Hospital at ... were all selected as Top Workplaces in Tampa Bay. ... is ranked number one for large businesses according to ... in partnership with an independent research firm. Florida Hospital ... opened in October of 2012 with a vision of ...
Breaking Medicine News(10 mins):Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 2Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 3Health News:Orange County Facial Plastic Surgeon Featured in Premier Magazine Focused on Beauty 2Health News:Orange County Facial Plastic Surgeon Featured in Premier Magazine Focused on Beauty 3Health News:Tampa Bay Times Selects Florida Hospital Wesley Chapel, Florida Hospital at Connerton Long Term Acute Care and Florida Hospital Carrollwood As Top Workplaces in Tampa Bay 2Health News:Tampa Bay Times Selects Florida Hospital Wesley Chapel, Florida Hospital at Connerton Long Term Acute Care and Florida Hospital Carrollwood As Top Workplaces in Tampa Bay 3Health News:Tampa Bay Times Selects Florida Hospital Wesley Chapel, Florida Hospital at Connerton Long Term Acute Care and Florida Hospital Carrollwood As Top Workplaces in Tampa Bay 4
... 2008 A new study in the Journal of Communication ... resources helps patients more than simply providing a list of URLs ... women and is the second leading cause of cancer death among ... the study set out to examine what type of access to ...
... 100 Most Wired hospitals show,better outcomes in patient satisfaction, ... use of information technology (IT),according to a new analysis. ... Study continues to lead the field in analyses and,benchmarking ... promise in helping us improve the,quality and safety of ...
... 15, 2008 The Procter &,Gamble Company (NYSE: PG ... to June quarter of fiscal year 2007/08. The company,continues to ... 10,percent, organic sales growth in line with previous guidance and ... for the quarter are not yet available. P&G is scheduled,to ...
... On the Increase, FREDERICK, Md., July 15 ... the company will,resume airing an investment and product-related ... Andrew Whelan says,"We previously ran this commercial in ... and product awareness. We are excited to see,these ...
... Processes, Products, and Research Presented in ... HBA Technical Conference Program, ... thinking,access to new innovation and recognition of the need for ... Expo Educational Program is more robust than ever.,More than 200 ...
... shown an association between certain past diagnostic radiation procedures ... a rare form of prostate cancer which affects about ... disease. , The study, the first of its kind ... from diagnostic procedures and the risk of prostate cancer, ...
Cached Medicine News:Health News:Focused Internet services provide better support to breast cancer patients 2Health News:Patient Satisfaction Higher at Most Wired Hospitals 2Health News:Patient Satisfaction Higher at Most Wired Hospitals 3Health News:Procter & Gamble Confirms Prior Sales and Earnings Guidance for Fourth Quarter 2007/08 2Health News:Procter & Gamble Confirms Prior Sales and Earnings Guidance for Fourth Quarter 2007/08 3Health News:BioElectronics Corporation's Commercial Resumes on Bloomberg Television 2Health News:BioElectronics Corporation's Commercial Resumes on Bloomberg Television 3Health News:R&D and Regulatory Leaders in the Cosmetics/Personal Care Field Present Latest Industry Research at HBA Global Expo 2Health News:R&D and Regulatory Leaders in the Cosmetics/Personal Care Field Present Latest Industry Research at HBA Global Expo 3Health News:Possible link found between X-rays and prostate cancer 2
... is a handheld, noninvasive ultrasound instrument that ... operate, so any staff member can scan ... images from exams and print BVI 6100 ... just log on to ScanPoint®, Diagnostic Ultrasound's ...
... The Mobile BladderScan® BVI 6400 calculates ... ultrasound technology. V-MODE® ultrasound is accurate, ... seconds, the BladderScan® measures ultrasonic reflections ... planes, creates a 3-dimensional image of ...
... EXP Injectable Bulking Agent is ... suspended in a water-based carrier ... Agent is indicated for the ... stress urinary incontinence due to ...
... The MIS is designed to ... in the area of the mid-urethra. ... 30 minutes, and can be performed ... department which allows the patient to ...
Medicine Products: